PRGO
Perrigo Company plc · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum inputs (comparable managers):
holder breadth -6.7% ·
share flow +20.5% ·
net new positions -7.1%
— formula
Concentrated accumulation — rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 101 | +2 | 113.09M | $1.17B | +10 | −7 |
| Q1 2026 | 101 | +4 | 101.94M | $1.09B | +11 | −8 |
| Q4 2025 | 98 | -2 | 106.62M | $1.48B | +3 | −4 |
| Q3 2025 | 19 | 0 | 63.63M | $1.42B | +1 | −2 |
| Q2 2025 | 17 | 0 | 58.29M | $1.56B | — | — |
| Q1 2025 | 14 | +1 | 29.73M | $833.59M | +1 | — |
| Q4 2024 | 13 | -2 | 24.99M | $642.39M | — | −2 |
| Q3 2024 | 14 | -1 | 13.07M | $342.69M | — | −1 |
| Q2 2024 | 15 | — | 10.85M | $278.70M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 3.16M | +42.3% | $82.78M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 3.16M | +42.3% | $82.78M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.70M | +229.2% | $70.76M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.70M | +229.2% | $70.76M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.70M | +229.2% | $70.76M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passive) | 2.36M | +4.7% | $61.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passive) | 2.36M | +4.7% | $61.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Norges Bank ✦ (passive) | 1.40M | +2.7% | $36.83M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | GAMCO Investors ✦ | 771.75K | -3.2% | $20.24M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 760.91K | -0.2% | $19.96M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 719.65K | -25.9% | $18.65M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 719.65K | -25.9% | $18.65M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 719.65K | -25.9% | $18.65M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Millennium Management ✦ | 613.47K | +35.8% | $16.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Arrowstreet Capital ✦ | 277.69K | -36.4% | $7.28M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 113.23K | +4.5% | $2.97M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 113.23K | +4.5% | $2.97M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 95.47K | -65.0% | $2.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 55.19K | -77.9% | $1.45M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Marshall Wace ✦ | 27.78K | +95.7% | $728,748 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 21.27K | -45.7% | $557,860 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Gotham Asset Management | $2.35M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 326 holders, 151.12M shares, $1.41B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.